Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Submission of scientific papers for publication (opens in new window)

Scientific papers on the findings submitted for publication in peerreviewed scientific and medical journals and respectively regulatory journals Preference will be given to submitting papers for publication in international openaccess scientific journals with as high impact as possible

Project website (opens in new window)

Launch of project website that provides project information background objectives approach results and news for selected stakeholders in clearly signposted sections for different users researchers collaborators clinicians patients etc

Intellectual Property Rights

5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY

Application/Publication number: 20 21000028
Date: 2021-03-24
Applicant(s): METRIOPHARM AG

LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION

Application/Publication number: 20 21000150
Date: 2021-12-01
Applicant(s): METRIOPHARM AG

COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS

Application/Publication number: 20 21000071
Date: 2021-06-09
Applicant(s): METRIOPHARM AG

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0